{"id":51651,"date":"2022-12-07T08:02:18","date_gmt":"2022-12-07T07:02:18","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/"},"modified":"2022-12-07T08:02:18","modified_gmt":"2022-12-07T07:02:18","slug":"delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/","title":{"rendered":"Delta-Fly Pharma, Inc. is granted Orphan Drug Designation by US Food and Drug Administration for DFP-10917"},"content":{"rendered":"
\n

TOKUSHIMA, Japan–(BUSINESS WIRE)–Delta-Fly Pharma, Inc. announces that DFP-10917, a leading pipeline of the company, is granted Orphan Drug Designation (ODD) by US Food and Drug Administration (FDA) for the treatment of Acute Myeloid Leukemia (AML).\n<\/p>\n

<\/a><\/p>\n

\nBe given to ODD, Delta-Fly Pharma, Inc. can be entitled to seven extra years of marketing exclusivity and receive some benefits such as R&D rebate by getting approval.\n<\/p>\n

\nDFP-10917 is an anti-cancer agent in development for the treatment of patients with Refractory\/Relapsed AML. A Phase 3 clinical study has been underway at MD Anderson Cancer Center in Texas and other major sites of Hematologic Cancer Treatment in USA. The company expects to complete the patients\u2019 enrollment plan soon.\n<\/p>\n

\nDelta-Fly Pharma, Inc. focuses not only on cancer itself but on the whole conditions of cancer patients, and aims to deliver medicines that are recommendable for cancer patients and their families.\n<\/p>\n\n\n\n\n\n\n\n\n\n
\n

\nCompany profile<\/span><\/b>\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nCompany name\n<\/p>\n<\/td>\n

\n

\nDelta-Fly Pharma, Inc. [Tokyo:4598]\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nCapital\n<\/p>\n<\/td>\n

\n

\n3352 million Japanese Yen\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nName and Title of Representative\n<\/p>\n<\/td>\n

\n

\nKiyoshi Eshima, PhD, President\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nDate of Incorporation\n<\/p>\n<\/td>\n

\n

\nDecember 6, 2010\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nDescription of Business\n<\/p>\n<\/td>\n

\n

\nResearch and development, manufacturing and marketing of pharmaceuticals\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nHead Office\n<\/p>\n<\/td>\n

\n

\n37-5, Nishikino, Miyajima, Kawauchi-cho, Tokushima 771-0116, Japan\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nBranch Office\n<\/p>\n<\/td>\n

\n

\nTokyo, Beijing, Vancouver\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\n\u00a0\n<\/p>\n

Contacts<\/b> <\/p>\n

\nDelta-Fly Pharma, Inc.
\n
Inquiries: Yasuo Matsueda
\n
TEL: +81-(0)3-6231-1278
\n
ymatsueda1206@delta-flypharma.co.jp<\/a>
https:\/\/www.delta-flypharma.co.jp\/en\/<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TOKUSHIMA, Japan–(BUSINESS WIRE)–Delta-Fly Pharma, Inc. announces that DFP-10917, a leading pipeline of the company, is granted Orphan Drug Designation (ODD) by US Food and Drug Administration (FDA) for the treatment of Acute Myeloid Leukemia (AML). Be given to ODD, Delta-Fly Pharma, Inc. can be entitled to seven extra years of marketing exclusivity and receive some … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51651","6":"format-standard","7":"category-industry"},"yoast_head":"\nDelta-Fly Pharma, Inc. is granted Orphan Drug Designation by US Food and Drug Administration for DFP-10917 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Delta-Fly Pharma, Inc. is granted Orphan Drug Designation by US Food and Drug Administration for DFP-10917 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TOKUSHIMA, Japan–(BUSINESS WIRE)–Delta-Fly Pharma, Inc. announces that DFP-10917, a leading pipeline of the company, is granted Orphan Drug Designation (ODD) by US Food and Drug Administration (FDA) for the treatment of Acute Myeloid Leukemia (AML). Be given to ODD, Delta-Fly Pharma, Inc. can be entitled to seven extra years of marketing exclusivity and receive some ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-07T07:02:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221206006153\/en\/1657667\/21\/Delta-Fly_Pharma_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Delta-Fly Pharma, Inc. is granted Orphan Drug Designation by US Food and Drug Administration for DFP-10917\",\"datePublished\":\"2022-12-07T07:02:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\\\/\"},\"wordCount\":235,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221206006153\\\/en\\\/1657667\\\/21\\\/Delta-Fly_Pharma_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\\\/\",\"name\":\"Delta-Fly Pharma, Inc. is granted Orphan Drug Designation by US Food and Drug Administration for DFP-10917 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221206006153\\\/en\\\/1657667\\\/21\\\/Delta-Fly_Pharma_logo.jpg\",\"datePublished\":\"2022-12-07T07:02:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221206006153\\\/en\\\/1657667\\\/21\\\/Delta-Fly_Pharma_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221206006153\\\/en\\\/1657667\\\/21\\\/Delta-Fly_Pharma_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Delta-Fly Pharma, Inc. is granted Orphan Drug Designation by US Food and Drug Administration for DFP-10917\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Delta-Fly Pharma, Inc. is granted Orphan Drug Designation by US Food and Drug Administration for DFP-10917 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/","og_locale":"en_US","og_type":"article","og_title":"Delta-Fly Pharma, Inc. is granted Orphan Drug Designation by US Food and Drug Administration for DFP-10917 - Pharma Trend","og_description":"TOKUSHIMA, Japan–(BUSINESS WIRE)–Delta-Fly Pharma, Inc. announces that DFP-10917, a leading pipeline of the company, is granted Orphan Drug Designation (ODD) by US Food and Drug Administration (FDA) for the treatment of Acute Myeloid Leukemia (AML). Be given to ODD, Delta-Fly Pharma, Inc. can be entitled to seven extra years of marketing exclusivity and receive some ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-07T07:02:18+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221206006153\/en\/1657667\/21\/Delta-Fly_Pharma_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Delta-Fly Pharma, Inc. is granted Orphan Drug Designation by US Food and Drug Administration for DFP-10917","datePublished":"2022-12-07T07:02:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/"},"wordCount":235,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221206006153\/en\/1657667\/21\/Delta-Fly_Pharma_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/","url":"https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/","name":"Delta-Fly Pharma, Inc. is granted Orphan Drug Designation by US Food and Drug Administration for DFP-10917 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221206006153\/en\/1657667\/21\/Delta-Fly_Pharma_logo.jpg","datePublished":"2022-12-07T07:02:18+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221206006153\/en\/1657667\/21\/Delta-Fly_Pharma_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221206006153\/en\/1657667\/21\/Delta-Fly_Pharma_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/delta-fly-pharma-inc-is-granted-orphan-drug-designation-by-us-food-and-drug-administration-for-dfp-10917\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Delta-Fly Pharma, Inc. is granted Orphan Drug Designation by US Food and Drug Administration for DFP-10917"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51651","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51651"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51651\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51651"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51651"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}